Patents by Inventor David Valenzuela

David Valenzuela has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20060085866
    Abstract: Methods of generating modified embryos and mammals by introduction of donor cells into an early stage embryo are provided, such that the resulting embryo and animal generated therefrom has a significant or complete contribution to all tissues from the donor cells and is capable of transmitting the donor cell DNA.
    Type: Application
    Filed: October 19, 2005
    Publication date: April 20, 2006
    Inventors: William Poueymirou, Thomas Dechiara, Wojtek Auerbach, David Frendewey, David Valenzuela
  • Publication number: 20060064770
    Abstract: Methods for modifying a mammalian cell target such that the presence of a Y chromosome is detectable. The method includes construction of a targeting vector with a detectable marker that can recombine or insert into a pre-selected site on the Y chromosome, allowing the presence of the Y chromosome to be detectable through the presence of the integrated detectable marker. The method can be used to distinguish male from female embryos.
    Type: Application
    Filed: September 15, 2005
    Publication date: March 23, 2006
    Inventors: David Frendewey, Wojtek Auerbach, Thomas Dechiara, David Valenzuela
  • Publication number: 20050144655
    Abstract: A method for engineering and utilizing large DNA vectors to target, via homologous recombination, and modify, in any desirable fashion, endogenous genes and chromosomal loci in eukaryotic cells. These large DNA targeting vectors for eukaryotic cells, termed LTVECs, are derived from fragments of cloned genomic DNA larger than those typically used by other approaches intended to perform homologous targeting in eukaryotic cells. Also provided is a rapid and convenient method of detecting eukaryotic cells in which the LTVEC has correctly targeted and modified the desired endogenous genes(s) or chromosomal locus (loci) as well as the use of these cells to generate organisms bearing the genetic modification.
    Type: Application
    Filed: October 31, 2001
    Publication date: June 30, 2005
    Inventors: Aris Economides, Andrew Murphy, David Valenzuela, David Frendewey, George Yancopoulos
  • Publication number: 20050101017
    Abstract: Methods of improving gene targeting comprising using a ubiquitin promoter to drive drug resistance gene expression are provided. Such improvements include increasing ES cell colony survival and targeting frequency.
    Type: Application
    Filed: November 10, 2003
    Publication date: May 12, 2005
    Inventors: Wojtek Auerbach, David Frendewey, Andrew Murphy, David Valenzuela
  • Publication number: 20050003543
    Abstract: Methods of creating mutations in genomic exons by inserting introns into the genomic exons via homologous recombination. Also, methods are provided for introducing modifications into genomic exons by inserting introns into the genomic exons via homologous recombination such that a mature mRNA transcript produced from a genomic region of the genome comprising the genomic exon does not contain the modification are provided. The methods provide for a rapid method for introducing mutations and/or modifications of any type into a mammalian cell genome.
    Type: Application
    Filed: June 10, 2004
    Publication date: January 6, 2005
    Inventors: Aris Economides, David Valenzuela, Samuel Davis, George Yancopoulos